Department of Occupational, Metabolic and Internal Diseases, Medical University of Gdańsk, 81-519 Gdynia, Poland.
Department of Preventive Medicine & Education, Medical University of Gdańsk, 80-210 Gdańsk, Poland.
Medicina (Kaunas). 2020 Jun 28;56(7):320. doi: 10.3390/medicina56070320.
Pharmacological therapy in the elderly is particularly complicated and challenging. Due to coexistence of three main predisposing factors (advanced age, multiple morbidity and polypharmacotherapy), this group of patients is prone to occurrence of drug interactions and adverse effects of incorrect drug combinations. Since many years patient safety during the treatment process has been one of key elements for proper functioning of healthcare systems around the world, thus different preventive measures have been undertaken in order to counteract factors adversely affecting the therapeutic effect. One of the avoidable medical errors is pharmacological interactions. According to estimates, one in six elderly patients may be at risk of a significant drug interaction. Hence the knowledge about mechanisms and causes of drug interactions in the elderly, as well as consequences of their occurrence are crucial for planning the process of pharmacotherapy. For the purpose of pharmacovigilance, a review of available methods and tools gives an insight into possible ways of preventing drug interactions. Additionally, recognizing the actual scale of this phenomenon in geriatric population around the world emphasizes the importance of a joint effort among medical community to improve quality of pharmacotherapy.
老年人的药物治疗特别复杂和具有挑战性。由于存在三个主要的诱发因素(高龄、多种疾病和多种药物治疗),这组患者容易发生药物相互作用和不正确药物组合的不良反应。多年来,患者在治疗过程中的安全一直是全球医疗保健系统正常运作的关键要素之一,因此采取了不同的预防措施来对抗影响治疗效果的不利因素。可避免的医疗错误之一是药物相互作用。据估计,六分之一的老年患者可能存在发生严重药物相互作用的风险。因此,了解老年人药物相互作用的机制和原因,以及其发生的后果,对于规划药物治疗过程至关重要。为了进行药物警戒,对现有方法和工具的审查提供了洞察可能预防药物相互作用的方法。此外,认识到世界各地老年人群体中这种现象的实际规模强调了医学界共同努力提高药物治疗质量的重要性。